SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (47)7/27/1999 2:01:00 PM
From: LLCF  Read Replies (2) of 427
 
I thought this was a great piece to get the shorts excited about their positions in small biotech. Its was found in the 'header' of the TM BIOSCIENCE CORP's SI link:

Subject 15945

<By Mr. Don MacAdam; President & CEO
TM Bioscience Corporation; TMC.V

Any one of the top 100 drugs represents sales of more than one
million dollars per day. There are new drugs on the horizon which will put every one of these top 100 drugs at risk of obsolescence.
In the near future, new, more efficacious medicines will take over
existing markets worth tens of billions of dollars. Where will these new drugs come from? The top twenty pharmaceutical companies are together working on only a few hundred new drugs, but the two thousand biotech companies are working on perhaps five thousand new drugs. Its a numbers game. The medicines of tomorrow are being discovered by smaller companies. And, the medicines of tomorrow will be worth a great deal of money. Therefore, I state the following as a fact: in the near future, some biotech companies, and their investors, will do very well.>

Keep shorting guys and gals!!!!!

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext